CID 513661
1,3-thiazol-5-ylmethyl {(1s,2r)-3-[(1,3-benzothiazol-6-ylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropyl}carbamate
Structural Information
- Molecular Formula
- C26H30N4O5S3
- SMILES
- CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)OCC2=CN=CS2)O)S(=O)(=O)C3=CC4=C(C=C3)N=CS4
- InChI
- InChI=1S/C26H30N4O5S3/c1-18(2)13-30(38(33,34)21-8-9-22-25(11-21)37-17-28-22)14-24(31)23(10-19-6-4-3-5-7-19)29-26(32)35-15-20-12-27-16-36-20/h3-9,11-12,16-18,23-24,31H,10,13-15H2,1-2H3,(H,29,32)/t23-,24+/m0/s1
- InChIKey
- UWZVTZMKOKPZHA-BJKOFHAPSA-N
- Compound name
- 1,3-thiazol-5-ylmethyl N-[(2S,3R)-4-[1,3-benzothiazol-6-ylsulfonyl(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 575.14508 | 230.1 |
[M+Na]+ | 597.12702 | 232.8 |
[M-H]- | 573.13052 | 236.6 |
[M+NH4]+ | 592.17162 | 235.3 |
[M+K]+ | 613.10096 | 228.3 |
[M+H-H2O]+ | 557.13506 | 223.9 |
[M+HCOO]- | 619.13600 | 233.9 |
[M+CH3COO]- | 633.15165 | 248.2 |
[M+Na-2H]- | 595.11247 | 231.1 |
[M]+ | 574.13725 | 237.3 |
[M]- | 574.13835 | 237.3 |
Literature stripe
Patent stripe
No patent data available for this compound.